LLY - Lilly gains approval of lebrikizumab in Canada for atopic dermatitis
2024-06-25 12:12:34 ET
More on Eli Lilly
- Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis)
- Eli Lilly: The Party Is Probably Nearing The End
- Eli Lilly And Alzheimer's Disease: The Paucity Of Progress
- Eli Lilly collaborates with OpenAI for medicines against drug-resistant bacteria
- Lilly, Novo Nordisk to dominate weight loss therapy market: SA Investing Summit